Nonetheless, in vitro binding assays using recombinant αSyn fibrils and fibrils from PD brain showed that αSyn has sufficient binding site density to enable in vivo imaging, which is similar to tau, but less than Aβ plaques.103. This evidence concerns the gene MAPT and Parkinson disease.